{"id":"W4399480918","doi":"10.1200/jco.2024.42.16_suppl.tps7577","title":"MagnetisMM-30: A phase 1b, open-label study of elranatamab in combination with iberdomide in patients with relapsed or refractory multiple myeloma (RRMM).","year":2024,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dr. Everett Chalmers Regional Hospital","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Refractory (planetary science); Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002071778,0.00210319,0.002163852,0.0006344413,0.0004900565,0.001206648,0.001281654,0.001778975,0.00417447],"category_scores_gemma":[0.0008604886,0.0009106697,0.001674372,0.0004083949,0.001030483,0.001153158,0.0004613512,0.004044615,0.001784459],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001260525,"about_ca_system_score_gemma":0.002090708,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001288529,"about_ca_topic_score_gemma":0.003711533,"domain_scores_codex":[0.999519,0.0002255789,0.00001857722,0.00008234326,0.00005497791,0.00009957796],"domain_scores_gemma":[0.9994211,0.0000692449,0.0001083143,0.00004061492,0.00003396307,0.0003267744],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6285104,0.1524186,0.005408008,0.001527367,0.001774564,0.0003939831,0.0005598647,0.003114989,0.06938655,0.0005853119,0.01098376,0.1253366],"study_design_scores_gemma":[0.6433422,0.3399431,0.008029346,0.00004200223,0.0003878144,0.0003235647,0.00005619576,0.001310344,0.002599939,0.0002599357,0.003657839,0.00004776],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9833052,0.004713296,0.0008648674,0.001406447,0.0002834965,0.004221746,0.001963974,0.0002996797,0.002941282],"genre_scores_gemma":[0.9779255,0.003294738,0.003292311,0.002787716,0.0003345246,0.004337196,0.003371059,0.00008097827,0.004575866],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00417447,"threshold_uncertainty_score":0.01396501,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1305628271357605,"score_gpt":0.4881922807704298,"score_spread":0.3576294536346692,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}